Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.

[1]  E. Fosse,et al.  Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[2]  L. Edmunds.  Surface-bound heparin--panacea or peril? , 1994, The Annals of thoracic surgery.

[3]  M. Pasic,et al.  Risk and benefit of low systemic heparinization during open heart operations. , 1994, The Annals of thoracic surgery.

[4]  B. Nilsson,et al.  Complement activation during cardiopulmonary bypass: effects of immobilized heparin. , 1994, The Annals of thoracic surgery.

[5]  G. Murray,et al.  Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator. , 1994, The Annals of thoracic surgery.

[6]  C. Greenberg,et al.  Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers , 1994, Anesthesiology.

[7]  H. Philippou,et al.  Thrombin Production, Inactivation and Expression during Open Heart Surgery Measured by Assays for Activation Fragments Including a New ELISA for Prothrombin Fragment F1+2 , 1993, Thrombosis and Haemostasis.

[8]  I. Kovács,et al.  Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. , 1993, The Journal of thoracic and cardiovascular surgery.

[9]  W. van Oeveren,et al.  Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[10]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[11]  M. Turina,et al.  Reduction and elimination of systemic heparinization during cardiopulmonary bypass. , 1992, The Journal of thoracic and cardiovascular surgery.

[12]  H. Hansson,et al.  Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. , 1992, Scandinavian journal of thoracic and cardiovascular surgery.

[13]  M. Abdelnoor,et al.  Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. , 1991, The Annals of thoracic surgery.

[14]  W. van Oeveren,et al.  Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass , 1991 .

[15]  M. Oppermann,et al.  Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.

[16]  H. Lindberg,et al.  Systemic and pulmonary circulatory effects of protamine following cardiopulmonary bypass in man. , 1991, Scandinavian journal of thoracic and cardiovascular surgery.

[17]  J. Horrow.  Protamine: A Review of its Toxicity , 1985, Anesthesia and analgesia.

[18]  L. Harker,et al.  Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. , 1984, The Journal of clinical investigation.

[19]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, Thorax.

[20]  H. Schaff,et al.  Cardiovascular effects of protamine sulfate in man. , 1982, The Journal of thoracic and cardiovascular surgery.

[21]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.